Michael S. Ryan Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$297K Buy
257
+24
+10% +$28.3K 0.15% 49
2026
Q2
$279K Buy
233
+15
+7% +$15.3K 0.14% 51
2026
Q1
$201K Buy
218
+5
+2% +$5.07K 0.12% 55
2025
Q4
$229K Buy
+213
New +$204K 0.13% 50

Other funds holding LLY

Michael S. Ryan Inc's LLY Position: Q3 2026 in Review

Michael S. Ryan Inc increased its Eli Lilly (LLY) stake by 10% in Q3 2026, buying an estimated $28.3K and bringing the position to 257 shares worth $297K. The position accounts for 0.15% of the portfolio, ranked #49.

Michael S. Ryan Inc first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 2,010 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Michael S. Ryan Inc held 257 shares of Eli Lilly worth $297K as of Q3 2026.
  • Michael S. Ryan Inc bought 24 Eli Lilly shares in Q3 2026, an estimated $28.3K.
  • Eli Lilly made up 0.15% of Michael S. Ryan Inc's portfolio in Q3 2026, its #49 holding.
  • Michael S. Ryan Inc first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 2,010 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Michael S. Ryan Inc's 13F filing for Q3 2026, filed 1 Oct 2026.